Search Results

Your search for Jeff Summers, MD, and Marc R. Theoret, MD matches 2 pages

Showing 1 - 2

By Julie A. Schneider, PhD; Jennifer J. Gao, MD; Martha B. Donoghue, MD; Lola Fashoyin-Aje, MD, MPH; Jeff Summers, MD; Paul G. Kluetz, MD; Marc R. Theoret, MD; and Richard Pazdur, MD / February 10, 2023

FDA Oncology Center of Excellence Seeks Applications for New Research Funding Opportunities

OCE Insights is an occasional column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Julie A. Schneider, PhD, Associate Director for Research Strategy and Partnerships, OCE; Jennifer J. Gao, MD,...

issues in oncology

By Jeff Summers, MD, and Marc R. Theoret, MD / January 25, 2022

Project Catalyst: Educating Industry to Help Develop Successful Cancer Therapies

OCE Insights is written by members of the Oncology Center of Excellence (OCE) and the Office of Oncology Diseases (OOD) at the U.S. Food and Drug Administration. In this installment, Jeff Summers, MD, OOD Acting Associate Director for Translational Sciences, and Marc R. Theoret, MD, OCE Deputy...

Search Results

Your search for Jeff Summers, MD, and Marc R. Theoret, MD matches 2 pages

FDA Oncology Center of Excellence Seeks Applications for New Research Funding Opportunities

Project Catalyst: Educating Industry to Help Develop Successful Cancer Therapies

Adagrasib Plus Cetuximab in KRAS G12C–Mutated Colorectal Cancer

Induction and Concurrent Vismodegib With Radiation Therapy for Locally Advanced Unresectable Basal Cell Carcinoma

FDA Approves Nogapendekin Alfa Inbakicept-pmln for BCG-Unresponsive Non–Muscle Invasive Bladder Cancer

Predicting Ovarian Cancer Relapse With Spatial Tissue Analysis

Chemohormonal Therapy for Locally Advanced Prostate Cancer